Muscle failure and risk of adverse outcomes in older adults: a derivation and multicohort validation study
Hélio José Coelho-Júnior, Alejandro Álvarez‐Bustos, Isabel Rodríguez-Sánchez, Francesco Landi, Emanuele Marzetti
Università Cattolica del Sacro Cuore Agostino Gemelli University Polyclinic Istituti di Ricovero e Cura a Carattere Scientifico Universidad Villanueva
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
BACKGROUND: Sarcopenia is inconsistently defined, and its definition might not adequately capture muscle failure, underlying disability, and other adverse outcomes in older adults. We aimed to develop and validate an evidence-based, outcome-driven model of muscle failure. METHODS: In this derivation and multicohort validation study, we analysed data from the SPRINTT randomised controlled trial (1519 participants; mean age 78·9 years [SD 5·8]; 431 [28·4%] men, 1088 (71·6%) women) and validated findings in five independent cohorts (ilSIRENTE, NHANES, HRS, ELSA, and CHARLS). Neuromuscular domains including appendicular lean mass, muscle strength and power, mobility, and physical activity were assessed. Principal component analysis identified clusters of measures, which were tested for associations with disability in mobility and disability in activities of daily living, hospitalisation, and mortality using adjusted regression models. Predictive performance was evaluated with receiver operating characteristic curves. Area under the curve (AUC) values were defined as acceptable (0·7-0·8), excellent (0·8-0·9), or outstanding (>0·9). FINDINGS: We identified two major muscle failure indexes: mobility (short-distance walking speed, 400 m walk) and physical activity (step counts, time spent standing, stepping, and sitting). In SPRINTT, the mobility model strongly predicted disability (AUC 0·721, 95% CI 0·698-0·795; p<0·0001), whereas the physical activity model was more closely associated with hospitalisation (0·646, 0·570-0·731; p=0·00040) and mortality (0·746, 0·612-0·926; p=0·0020). Combined models including mobility, handgrip strength, appendicular lean mass, and absolute muscle power improved prediction of mortality (0·746, 0·549-0·955; p=0·0076). External validation confirmed acceptable-to-strong discrimination for disability outcomes across cohorts (AUCs 0·7-0·9), while associations with hospitalisation and mortality were weaker and inconsistent (0·4-0·9). Compared with consensus-based sarcopenia definitions, the evidence-based model seemed to show better predictive ability for disability. INTERPRETATION: Distinct mobility measures provide a robust framework for identifying muscle failure and predicting disability in older adults. Continuous activity monitoring might improve prediction of hospitalisation and mortality. This outcome-driven approach supports refinement of sarcopenia assessment and its implementation in clinical practice. FUNDING: None.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Nutrition and Health in Aging
Frailty in Older Adults · Aging, Health, and Disability
参考文献 30
此处列出前 3 条
引用本文 1
按被引量排序,此处列出前 3 条